The dry powder formulation of mixed cross-linked dextran microspheres and tetanus toxoid-loaded trimethyl chitosan nanospheres as a potent adjuvant for nasal delivery system

Publish Year: 1400
نوع سند: مقاله ژورنالی
زبان: English
View: 242

This Paper With 7 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJBMS-24-1_017

تاریخ نمایه سازی: 19 دی 1399

Abstract:

Objective(s): The present study aimed to determine the immunoadjuvant efficacy of mixed cross-linked dextran microspheres (CDM) and tetanus toxoid (TT)-loaded trimethyl chitosan (TMC) nanospheres in dry powder form. Materials and Methods: The TMC nanoparticles (NPs) containing TT were produced using the ionic gelation method. Co-administration of TT-loaded TMC NPs and CDM as an absorption enhancer was performed to improve immunity against the antigen. Dry powder formulations were delivered via the nasal route in a rabbit model. Results: Among immunization groups, mixing of CDM with TT encapsulated in TMC NPs could elicit the highest titer of systemic IgG antibody. Furthermore, the addition of CDM to TT-loaded TMC enhanced the sIgA response relative to the TT solution. Conclusion: The TMC NPs had a considerable effect on mucosal and systemic immunity against the TT antigen. Therefore, the CDM excipient can be utilized for nasal immunization to elevate systemic and mucosal responses.

Keywords:

Cross , linked dextran microspheres Mucosal immunity Nasal immunization Systemic responses Tetanus toxoid Trimethyl chitosan nanoparticles

Authors

Mona Kabiri

Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

Haleh Bolourian

School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Solmaz Dehghan

Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

Mohsen Tafaghodi

Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • 1. Chen H. Recent advances in mucosal vaccine development. J ...
  • 2. Lycke N. Recent progress in mucosal vaccine development: potential ...
  • 3. Mannam P, Jones KF, Geller BL. Mucosal vaccine made ...
  • 4. Pavot V, Rochereau N, Genin C, Verrier B, Paul ...
  • 5. Rhee JH, Lee SE, Kim SY. Mucosal vaccine adjuvants ...
  • 6. Tafaghodi M, Tabassi SAS, Jaafari MR. Induction of systemic ...
  • 7. Ramvikas M, Arumugam M, Chakrabarti S, Jaganathan K. Nasal ...
  • 8. Peterson LW, Artis D. Intestinal epithelial cells: regulators of ...
  • 9. Kiyono H, Fukuyama S. NALT-versus Peyer’s-patch-mediated mucosal immunity. Nat ...
  • 10. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Recent advances on ...
  • 11. Fernández-Urrusuno R, Calvo P, Remuñán-López C, Vila-Jato JL, Alonso ...
  • 12. Illum L, Jabbal-Gill I, Hinchcliffe M, Fisher A, Davis ...
  • 13. Pan Y, Li Y-j, Zhao H-y, Zheng J-m, Xu ...
  • 14. Pawar D, Jaganathan K. Mucoadhesive glycol chitosan nanoparticles for ...
  • 15. Prasanth Koppolu B, Smith SG, Ravindranathan S, Jayanthi S, ...
  • 16. Channarong S, Chaicumpa W, Sinchaipanid N, Mitrevej A. Development ...
  • 17. Castro KCd, Costa JM, Campos MGN. Drug-loaded polymeric nanoparticles: ...
  • 18. Matos BN, Pereira MN, Bravo MdO, Cunha-Filho M, Saldanha-Araújo ...
  • 19. Sayın B, Somavarapu S, Li X, Thanou M, Sesardic ...
  • 20. Van der Lubben IM, Verhoef JC, Borchard G, Junginger ...
  • 21. Zhang H, Oh M, Allen C, Kumacheva E. Monodisperse ...
  • 22. Casettari L, Illum L. Chitosan in nasal delivery systems ...
  • 23. Yan Y, Sun Y, Wang P, Zhang R, Huo ...
  • 24. Tsai L-C, Chen C-H, Lin C-W, Ho Y-C, Mi ...
  • 25. Amidi M, Romeijn SG, Borchard G, Junginger HE, Hennink ...
  • 26. Bal SM, Slütter B, Verheul R, Bouwstra JA, Jiskoot ...
  • 27. Hagenaars N, Mania M, de Jong P, Que I, ...
  • 28. Amidi M, Romeijn SG, Verhoef JC, Junginger HE, Bungener ...
  • 29. Hagenaars N, Verheul RJ, Mooren I, de Jong PH, ...
  • 30. Slütter B, Bal S, Keijzer C, Mallants R, Hagenaars ...
  • 31. Slütter B, Jiskoot W. Dual role of CpG as ...
  • 32. Subbiah R, Ramalingam P, Ramasundaram S, Park K, Ramasamy ...
  • 33. Wang JJ, Zeng ZW, Xiao RZ, Xie T, Zhou ...
  • 34. Ariaee FM, Tafaghodi M. Mucosal adjuvant potential of Quillaja ...
  • 35. Mohaghegh M, Tafaghodi M. Dextran microspheres could enhance immune ...
  • 36. Pirouzmand H, Khameneh B, Tafaghodi M. Immunoadjuvant potential of ...
  • 37. Sahu KK, Pandey RS. Development and characterization of HBsAg-loaded ...
  • 38. Sieval A, Thanou M, Kotze A, Verhoef J, Brussee ...
  • 39. Diwan M, Tafaghodi M, Samuel J. Enhancement of immune ...
  • 40. Garmise RJ, Staats HF, Hickey AJ. Novel dry powder ...
  • 41. Tafaghodi M, Rastegar S. Preparation and in vivo study ...
  • 42. Scheerlinck J-PY, Greenwood DL. Virus-sized vaccine delivery systems. Drug ...
  • 43. Zaman M, Good MF, Toth I. Nanovaccines and their ...
  • 44. Zhao L, Seth A, Wibowo N, Zhao C-X, Mitter ...
  • 45. Kabiri M, Sankian M, Sadri K, Tafaghodi M. Robust ...
  • 46. Foged C, Brodin B, Frokjaer S, Sundblad A. Particle ...
  • 47. Nakanishi T, Kunisawa J, Hayashi A, Tsutsumi Y, Kubo ...
  • 48. Niikura K, Matsunaga T, Suzuki T, Kobayashi S, Yamaguchi ...
  • 49. Illum L, Jørgensen H, Bisgaard H, Krogsgaard O, Rossing ...
  • 50. Türker S, Onur E, Ózer Y. Nasal route and ...
  • 51. Sajeesh S, Bouchemal K, Marsaud V, Vauthier C, Sharma ...
  • 52. Tao Liang M, Davies NM, Blanchfield JT, Toth I. ...
  • 53. Steinhoff U, Visekruna A. Mucosal immunity and inflammation.  Methods ...
  • 54. Kabiri M, Sankian M, Hosseinpour M, Tafaghodi M. The ...
  • 55. Garmise RJ, Mar K, Crowder TM, Hwang CR, Ferriter ...
  • 56. Şenel S. Current status and future of chitosan in ...
  • 57. Tabassi SAS, Tafaghodi M, Jaafari MR. Induction of high ...
  • 58. Tafaghodi M, Eskandari M. The mucosal adjuvant potential of ...
  • 59. Chandler SG, Ilium L, Thomas NW. Nasal absorption in ...
  • نمایش کامل مراجع